Legrand, Charles – Trademark Portfolio
Entity Type: 01
Legrand, Charles holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 29 (Meats & Processed Foods) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ATCO. The owner is based in 14000 Caen.
Les Ombrages III
14 Avenue de Creully
14000 Caen , FR
Showing of trademarks Trademarks
Trademark Classifications
Legrand, Charles's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does Legrand, Charles have?
Legrand, Charles has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 cancelled.
What trademark classes does Legrand, Charles file in?
Legrand, Charles files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods), Class 1 (Chemicals), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Legrand, Charles's most well-known trademarks?
Legrand, Charles's registered trademark portfolio includes well-known marks such as ATCO. These are among 1 currently registered trademark in the portfolio.
What is Legrand, Charles's trademark registration success rate?
Legrand, Charles has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.